Thu, March 28, 2013
Wed, March 27, 2013
[ Wed, Mar 27th 2013 ]: Market Wire
Funding update
Tue, March 26, 2013
Mon, March 25, 2013
Fri, March 22, 2013
Thu, March 21, 2013
Wed, March 20, 2013
Tue, March 19, 2013

Matthew Harrison Maintained (BIIB) at Buy with Increased Target to $188 on, Mar 25th, 2013


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-188-on-mar-25th-2013.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation



Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $177 to $188 on, Mar 25th, 2013.

Matthew has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Matthew's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Christopher Raymond of "Piper Sandler" Downgraded from Buy to Hold and Decreased Target to $166 on, Thursday, January 3rd, 2013
  • Jay Olson of "Oppenheimer" Maintained at Hold with Decreased Target to $141 on, Thursday, January 3rd, 2013


These are the ratings of the 3 analyists that currently disagree with Matthew


  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $200 on, Monday, March 4th, 2013
  • Sumant Kulkarni of "Canaccord Genuity" Upgraded from Hold to Strong Buy and Increased Target to $187 on, Wednesday, February 27th, 2013
  • Andrew Peters of "Deutsche Bank" Maintained at Strong Buy with Increased Target to $170 on, Wednesday, February 6th, 2013

Publication Contributing Sources